Axcella Health Inc.
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is …
Biotechnology
US, Cambridge [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Axcella Health Inc. (AXLA) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - - Average | - - | - - | - - | 633,885.37 | 22,815.40 | 2,576.01 | 1,077.64 | 819.21 | 0.00 | 24.8448 | 57.56 | -0.4675 | -16.7749 | -0.07 | -0.65 | 6.3715 | - - | |
| Maximum | - - | - - | - - | 66,761,212.00 | 1,187,075.00 | 264,468.00 | 99,050.00 | 262,089.00 | 0.02 | 1,336.3467 | 3,715.80 | 3.0051 | 85.3485 | 0.40 | 2.21 | 73.1011 | - - | |
| Minimum | - - | - - | - - | 0.00 | -5.00 | -10,603.00 | -56,335.00 | -50,658.00 | 0.00 | -233.7460 | -132.82 | -101.7758 | -1,444.7800 | -1.56 | -84.15 | 0.0000 | - - | |
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.